Urgent Action Needed to Spur Antibiotic Innovation

Updated research from Pew and the WHO in the Global AMR R&D Hub shows not enough drugs are in development to meet patient needs

Urgent Action Needed to Spur Antibiotic Innovation

The World Health Organization, The Pew Charitable Trusts, and Global AMR R&D Hub are urging policymakers and innovation stakeholders to stimulate the insufficient global antibiotic pipeline. The call to action follows analyses from the WHO and Pew released earlier this year—and compiled in a Dynamic Dashboard by Global AMR R&D Hub—that conclude there are not enough new antibiotics in clinical development to meet patient needs worldwide.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Philadelphia Museum of Art